2022 Event Sponsors | BioJapan

Asia‘s Premier Hybrid Partnering Event

Oct 9Wed - 11Fri. 2024| PACIFICO Yokohama

Japanese

HOME
About
Exhibition
Seminar
Partnering
Attend

2022 Event Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Media & Promotion Partners

Global Partners

HOME
About
Exhibition
Seminar
Partnering
Attend

Download Event Logo For press

Contact　* If you have any questions, please contact us via an email.

Organizers

Secretariat of BioJapan
c/o JTB Communication Design, Inc.
Celestine Shiba Mitsui Building, 3-23-1, Shiba, Minato-ku, Tokyo, Japan 105-8335
email: biojapan@jtbcom.co.jp

BioJapan Organizing Committee
JTB Communication Design, Inc.

Secretariat of Regenerative Medicine Japan
c/o JTB Communication Design, Inc.
Celestine Shiba Mitsui Building, 3-23-1, Shiba, Minato-ku, Tokyo, Japan 105-8335
email: saisei@jtbcom.co.jp

Forum for Innovative Regenerative Medicine (FIRM)
Japan Bioindustry Association (JBA)
JTB Communication Design, Inc.

Secretariat of healthTECH JAPAN
c/o JTB Communication Design, Inc.
Celestine Shiba Mitsui Building, 3-23-1, Shiba, Minato-ku, Tokyo, Japan 105-8335
email: healthtech@jtbcom.co.jp

Japan Bioindustry Association (JBA)
JTB Communication Design, Inc.

Co-located with

Partner Events

About the Handling of Personal Information Solicitation Warning

BioJapan: Asia's Premier Partnering Event for the Global Biotechnology Industry

First edition was held back in 1986 and is the world's oldest event with a focus on biotechnology.
Since the 2000s, it has continued to grow as a business trade show, and in 2023 it will be on the 25th edition.
Biotechnology is expected to be applied in a wide range of fields such as drug discovery, personalized medicine,
regenerative medicine, diagnostic / medical equipment, research equipment / reagents, as well as environment / energy and functional foods in recent years.
BioJapan will accelerate open innovation in the biotechnology industry through exhibitions, seminars and partnering programs.

Organizers：BioJapan Organizing Committee
Organizers：JTB Communication Design, Inc.

Regenerative Medicine JAPAN:

Efforts for research and its practical application are becoming active especially after the 2012 Nobel Prize in Physiology or Medicine by Professor Kyoto University and also with the establishment of the "Regenerative Medicine Laws and Regulations" in 2014. However, although the R&D market for advancing regenerative medicine technology has been rising for a long time, the current issue is that there are few products on the market in Japan compared to Western countries and South Korea. Not only as an exhibition where cutting-edge research, results, products and technologies are gathered, but also through holding many global seminars and conducting business negotiations using a matching system that has the only functionality in Japan's exhibition. We will accelerate the practical application and industrialization of medical treatment.

Organizers：Forum for Innovative Regenerative Medicine (FIRM)
Organizers：Japan Bioindustry Association (JBA)
Organizers：JTB Communication Design, Inc.

healthTECH JAPAN: Accelerating Healthcare Industry with Digital Technology

With the current status, we understand this is a difficult time for all of us and it is affecting people’s connection in different ways, bringing a constant stream of changes.
healthTECH JAPAN wants to ensure they keep the community connected in such this situation.
As an accomplishment on the goal, this is what our digital platform offers your business to help the necessary precautions to be integrating between healthcare and digital technology as follows;
Through developing alliance partners of AI drug discovery, or to find most preferred users of medical devise and digital treatment apps.
Plus, all of you can expect your business synergies with BioJapan as a concurrent, one of the largest partnering events in Asia.

Organizers：Japan Bioindustry Association (JBA)
Organizers：JTB Communication Design, Inc.

© 2023 JTB Communication Design, Inc. All rights reserved.